The Influence of Tissue Ischemia on Biomarker Expression in Colorectal Cancer

被引:0
|
作者
Havelund, Birgitte M. [1 ,4 ]
Olsen, Dorte A. [2 ]
Andersen, Rikke F. [2 ]
Spindler, Karen-Lise G. [1 ,4 ]
Brandslund, Ivan [2 ,4 ]
Jakobsen, Anders [1 ,4 ]
Soerensen, Flemming B. [3 ,4 ]
机构
[1] Vejle Hosp, Dept Oncol, DK-7100 Vejle, Denmark
[2] Vejle Hosp, Dept Clin Biochem, DK-7100 Vejle, Denmark
[3] Vejle Hosp, Dept Clin Pathol, DK-7100 Vejle, Denmark
[4] Univ Southern Denmark, Inst Reg Hlth Serv Res, Odense, Denmark
关键词
biomarker; colorectal cancer; delayed fixation; hypoxia; ischemia; SURGICALLY INDUCED ISCHEMIA; PARAFFIN-EMBEDDED TISSUE; GENE-EXPRESSION; RECTAL-CANCER; FORMALIN FIXATION; WARM ISCHEMIA; COLON-CANCER; HYPOXIA; PROLIFERATION; PROTEIN;
D O I
暂无
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
The aim of the present study was to investigate the influence of fixation delay and the perioperative ischemia on hypoxia inducible factor (HIF)-1 alpha gene expression, HIF-1 alpha protein expression, and immunohistochemical (IHC) expression of HIF-1 alpha, GLUT-1, Bcl-2, and Ki-67 in colorectal cancer. The study included 25 surgically removed colorectal tumors. Three sets of samples were collected readily after removal and exposed to 0, 30, and 60 minutes of delay of fixation or freezing. The perioperative ischemia time was registered. In each set of the samples, HIF-1 alpha gene expression was analyzed by quantitative real time polymerase chain reaction, protein concentration of HIF-1 alpha was assessed by enzyme-linked immunosorbent assay, and IHC staining of HIF-1 alpha, GLUT-1, Bcl-2, and Ki-67 was performed. Preoperative formalin-fixed paraffin-embedded biopsies and whole sections of the entire tumor were analyzed by IHC. We found that the HIF-1 alpha gene expression, HIF-1 alpha protein concentration, and IHC expression of HIF-1 alpha, GLUT-1, Ki-67, and Bcl-2 were not systematically affected by either the fixation or freezing delay of the tissue, the perioperative ischemia time, or the total ischemia time (perioperative ischemia + delay of fixation or freezing) in colorectal tumors. However, the intraindividual variation was quite large, which may question the use of individually, non-standardized-handled single biopsies or small tissue samples for analysis of often rather heterogenously expressed biomarkers.
引用
收藏
页码:298 / 307
页数:10
相关论文
共 50 条
  • [41] Differential Expression and Prognostic Role of Selected Genes in Colorectal Cancer Patients
    Pitule, Pavel
    Vycital, Ondrej
    Bruha, Jan
    Novak, Petr
    Hosek, Petr
    Treska, Vladislav
    Hlavata, Ivona
    Soucek, Pavel
    Kralickova, Milena
    Liska, Vaclav
    ANTICANCER RESEARCH, 2013, 33 (11) : 4855 - 4865
  • [42] Prognostic significance of monocarboxylate transporter 4 expression in patients with colorectal cancer
    Nakayama, Yoshifumi
    Torigoe, Takayuki
    Inoue, Yuzuru
    Minagawa, Noritaka
    Izumi, Hiroto
    Kohno, Kimitoshi
    Yamaguchi, Koji
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (01) : 25 - 30
  • [43] Identification of biomarker microRNAs for predicting the response colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network
    Zhu, Yaqun
    Peng, Qiliang
    Lin, Yuxin
    Zou, Li
    Shen, Peipei
    Chen, Feifei
    Min, Ming
    Shen, Li
    Chen, Jiajia
    Shen, Bairong
    ONCOTARGET, 2017, 8 (02) : 2233 - 2248
  • [44] Intensive Radiographic and Biomarker Surveillance in Stage II and III Colorectal Cancer
    Fora, Ahmad
    Patta, Annie
    Attwood, Kristopher
    Wilding, Gregory
    Fakih, Marwan
    ONCOLOGY, 2012, 82 (01) : 41 - 47
  • [45] MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer
    Cheng, Lin-Yao
    Huang, Mao-Sen
    Zhong, Hua-Ge
    Ru, Hai-Ming
    Mo, Si-Si
    Wei, Chun-Yin
    Su, Zi-Jie
    Mo, Xian-Wei
    Yan, Lin-Hai
    Tang, Wei-Zhong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [46] Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer
    Zuurbier, Linda
    Rahman, Arman
    Cordes, Martijn
    Scheick, Jennifer
    Wong, Tse J.
    Rustenburg, Francois
    Joseph, Jesu Christopher
    Dynoodt, Peter
    Casey, Rory
    Drillenburg, Paul
    Gerhards, Michael
    Barat, Ana
    Klinger, Rut
    Fender, Bozena
    O'Connor, Darran P.
    Betge, Johannes
    Ebert, Matthias P.
    Gaiser, Timo
    Prehn, Jochen H. M.
    Griffioen, Arjan W.
    van Grieken, Nicole C. T.
    Ylstra, Bauke
    Byrne, Annette T.
    van der Flier, Laurens G.
    Gallagher, William M.
    Postel, Ruben
    ONCOTARGET, 2017, 8 (26) : 42949 - 42961
  • [47] Circulating miR-210 as a diagnostic and prognostic biomarker for colorectal cancer
    Wang, W.
    Qu, A.
    Liu, W.
    Liu, Y.
    Zheng, G.
    Du, L.
    Zhang, X.
    Yang, Y.
    Wang, C.
    Chen, X.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (04)
  • [48] Expression of specific microRNAs in tissue and plasma in colorectal cancer
    Fellizar, Allan
    Refuerzo, Vivencio
    Ramos, John Donnie
    Albano, Pia Marie
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2023, 57 (03) : 147 - 157
  • [49] Study of carcinoembryonic antigen tissue expression in colorectal cancer
    Zedan S.
    Morshed M.
    Khafagy W.
    Ahmed S.
    El-Hossini F.
    El-Shobaky M.
    coloproctology, 2001, 23 (2) : 88 - 93
  • [50] Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
    Matsumura, T.
    Sugimachi, K.
    Iinuma, H.
    Takahashi, Y.
    Kurashige, J.
    Sawada, G.
    Ueda, M.
    Uchi, R.
    Ueo, H.
    Takano, Y.
    Shinden, Y.
    Eguchi, H.
    Yamamoto, H.
    Doki, Y.
    Mori, M.
    Ochiya, T.
    Mimori, K.
    BRITISH JOURNAL OF CANCER, 2015, 113 (02) : 275 - 281